Dmitry Kaminskiy, presents AI in Pharma Investment Trends: Major Take-Aways

Dmitry Kaminskiy - presents at NeuroTech2020 major takeouts from the NeuroTech 2020 Industry Report.

On 7th May 2019 Dmitry Kaminskiy, Managing Partner at Deep Knowledge Ventures and Founder of Aging Analytics Agency, together with Eric Kihlstrom, Director of Aging Analytics Agency, delivered a presentation on the emerging Longevity industry at the London's Reform Club

Dmitry Kaminskiy on behalf of Aging Analytics Agency presented key findings from the agency’s 265-page open-access report on government-led Longevity development plans at the All-Party Parliamentary Group for Longevity Strategic Advisory Board meeting, which took place in UK Parliament on 30 April 2019.

Far from the evil cyborgs of science fiction, AI is emerging as a sustainable investment theme

A major report by Big Innovation Centre and Deep Knowledge Analytics places the UK in the third spot in the global rankings for Artificial Intelligence (AI) and it foresees it excelling in specific subsectors and areas in the coming years.

Representatives from Deep Knowledge Analytics, Big Innovation Centre, and the All Party Parliamentary Group on Blockchain presented their landmark report, Blockchain in UK Industry Landscape Overview 2018, at the reception in  UK parliament.

On September 4th Dmitry Kaminskiy participated in two Panel Sessions at the 2018 Disruption Summit hosted by UK Research and Innovation.

On September 12, 2018, Dmitry Kaminskiy delivered a keynote presentation at AFM 2018, one of the leading FinTech conferences for professional incumbents and leading players of the financial industry in the UK.

On June 10 2018, Dmitry Kaminskiy participated in a panel discussion titled “Tech Meets Trust” moderated by Mo Gawdat, former Chief Business Officer for Google X, on the subject of Artificial Intelligence and Longevity.

On May 2, 2018 Dmitry Kaminskiy spoke at Glaxo Smith Kline's 2018 Hub in a Day event on how the intersection of AI, Longevity and Precision Medicine are poised to disrupt the BioPharma Industry.

In the beginning of 2018, UK Parliamentary members established the All Party Parliamentary Group on Blockchain in order to better coordinate the work of multiple initiatives by Government and Non-Governmental organizations. This committee regularly organizes meetings with leaders of the industry and top experts.